It is currently Sat Sep 20, 2014 3:11 am

News News of Sativex

Site map of Sativex » Forum : Sativex

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

Cannabis-based oral spray approved for use in Ireland

Cannabis-based oral spray approved for use in Ireland

The Irish medical board has approved a cannabis-based spray, which can ease symptoms and significantly improve the quality of life of people suffering from illnesses like multiple sclerosis....... Read More - http://www.ms-uk.org/index.cfm/MSnews
Read more : Cannabis-based oral spray approved for use in Ireland | Views : 1028 | Replies : 0


No strong evidence to back use of cannabis extract in MS

Image

There is no strong evidence to back the use of cannabis extract in the treatment of Multiple Sclerosis (MS), concludes a review of the available evidence on the first licensed preparation, published in the December issue of Drug and Therapeutics Bulletin (DTB).

Sativex, in the form of a mouth spray, contains the principal extracts—dronabinol and cannabidiol—found in the leaf and flower of the cannabis plant. It is the first cannabinoid preparation to be licensed ...
Read more : No strong evidence to back use of cannabis extract in MS | Views : 1356 | Replies : 1


Trial Brings Cannabis Spray Sativex Closer To Pharmacies

HI Friends
http://www.southernhighlandnews.com.au/ ... harmacies/
THIS IS IN TODAYS SYDNEY MORNING HERALD PAPER. SOON THE TRIAL IN AUSTRALIA PLEASE READ THE WEB FORMOR INFORMATIONS
regards
seeva
Read more : Trial Brings Cannabis Spray Sativex Closer To Pharmacies | Views : 1190 | Replies : 0


Positive new Sativex® data from Germany presented at ECTRIMS

Image

Almirall S.A. announced that results of the MObility ImproVEments with Spasticity in Multiple Sclerosis (MOVE) 2 observational study performed in Germany, with 300 patients, showed that one month's treatment with Sativex®(THC:CBD) oromucosal spray reduces moderate to severe multiple sclerosis spasticity (MSS) by 20% or more in 4 out of 10 patients previously unresponsive to conventional therapies. After three months, the improvement observed was 30% or more. Overall, 55% of the initial patients were eligible ...
Read more : Positive new Sativex® data from Germany presented at ECTRIMS | Views : 1008 | Replies : 0


Sativex for spasticity due to MS: added benefit not proven

Image

An extract from the plant Cannabis sativa (trade name Sativex®) was approved in May 2011 for patients suffering from moderate to severe spastic paralysis and muscle spasms due to multiple sclerosis (MS). In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether the new drug, which is used as a mouth spray, ...
Read more : Sativex for spasticity due to MS: added benefit not proven | Views : 998 | Replies : 0


Sativex long-term use: an open-label trial

Sativex long-term use: an open-label trial in patients with spasticity due to MS

Image

Summary: This new study from a research group in Scotland assesses the long term safety profile of regular Sativex use for spasticity in MS.

The report, which follows-up 146 patients using treatment for a mean duration of 334 days, administering a mean of 7.3 actuations per day, found that 36% withdrew in the first year, either due to adverse events of ...
Read more : Sativex long-term use: an open-label trial | Views : 1169 | Replies : 0


Sativex® mutual recognition procedure closes

Sativex® mutual recognition procedure closes with recommendation for approval in ten european countries

Image


GW Pharmaceuticals plc and Almirall S.A. today announce the successful completion of the European Mutual Recognition Procedure (MRP) for Sativex® oromucosal spray in the treatment of spasticity due to Multiple Sclerosis (MS).

Following previous positive regulatory submissions in the UK, Spain, Germany, Italy, Denmark Sweden, Austria, Czech Republic, a MRP application was made to expand the availability of Sativex® to ten ...
Read more : Sativex® mutual recognition procedure closes | Views : 1205 | Replies : 0


Sweden approves medical 'marijuana' spray Sativex for MS

Image

Medicinal cannabis is now available as a prescription medicine in Sweden after the Medical Products Agency (Läkemedelsverket) approved a cannabis-based mouth spray for the treatment of multiple sclerosis (MS).

"This is great news for those who can't get any relief from the most common drugs," said Jan Hillert, an MS researcher at Karolinska Institutet, to the Dagens Nyheter daily.

The agency has said that it plans to closely monitor the prescription of the new ...
Read more : Sweden approves medical 'marijuana' spray Sativex for MS | Views : 1489 | Replies : 0




My Doctor's Opinion

Greetings All...

I took various Sativex documents to my GP for her to read and decide if I was a good candidate for the drug.

As I handed them over to her, she said "is this that cannabis spray"?

I said yes, what do you think?

Before I could finish that short question she put her hands up in front of her and backed up quickly (banging into a table).

Anyone watching this would have ...
Read more : My Doctor's Opinion | Views : 4472 | Replies : 19


 

Login  •  Register


Statistics

Total posts 220036 • Total topics 22749 • Total members 14356


Contact us | Terms of Service